Search research articles
Contact Us
Filters
Showing results (351-360 of 595) with videos related to
Page
of 60
Sort By:
Revue Medicale De Liege
|
June 26, 2001
[Physical exercise for preventing obesity, promoting weight loss and maintaining weight management]
A J Scheen, M Rorive, M Letiexhe
Revue Medicale De Liege
|
June 12, 2009
[Incidence of restenosis and cardiac events after coronary angioplasty in diabetic patients: reduction by systemic pharmacological approaches]
A Nyssen, V Legrand, A J Scheen
Revue Medicale De Liege
|
February 10, 2022
[Bempedoïc acid, new cholesterol-lowering drug]
A J Scheen, N Paquot, C Wallemacq
Revue Medicale De Liege
|
March 24, 2004
[Hematochromatosis and diabetes]
V Thielen, N Paquot, A J Scheen
Revue Medicale De Liege
|
January 14, 2005
[Percutaneous coronary angioplasty in diabetic patients. Part II: hopes based on endovascular prosthesis]
F Warzée, V Legrand, A J Scheen
Revue Medicale De Liege
|
April 11, 2002
[How I explore ... the risk of a patient developing type 2 diabetes]
A J Scheen, N Paquot, B Jandrain
Diabetes & Metabolism
|
March 22, 2015
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
A J Scheen, N Esser, N Paquot
Revue Medicale De Liege
|
May 27, 2010
[Fitness versus fatness: respective cardiometabolic impacts at different age ranges]
N Esser, N Paquot, A J Scheen
Revue Medicale Suisse
|
September 16, 2006
[Drug therapy in the elderly. What should we know?]
P Wotquenne, J Petermans, A J Scheen
Diabetes & Metabolism
|
April 7, 2007
Abnormal glucose metabolism in patients treated with antipsychotics
A J Scheen, M A De Hert
Page
of 60
Search research articles
Search
Showing results (351-360 of 595) with videos related to
Sort By:
Page
of 60
Revue Medicale De Liege
|
June 26, 2001
[Physical exercise for preventing obesity, promoting weight loss and maintaining weight management]
A J Scheen, M Rorive, M Letiexhe
Revue Medicale De Liege
|
June 12, 2009
[Incidence of restenosis and cardiac events after coronary angioplasty in diabetic patients: reduction by systemic pharmacological approaches]
A Nyssen, V Legrand, A J Scheen
Revue Medicale De Liege
|
February 10, 2022
[Bempedoïc acid, new cholesterol-lowering drug]
A J Scheen, N Paquot, C Wallemacq
Revue Medicale De Liege
|
March 24, 2004
[Hematochromatosis and diabetes]
V Thielen, N Paquot, A J Scheen
Revue Medicale De Liege
|
January 14, 2005
[Percutaneous coronary angioplasty in diabetic patients. Part II: hopes based on endovascular prosthesis]
F Warzée, V Legrand, A J Scheen
Revue Medicale De Liege
|
April 11, 2002
[How I explore ... the risk of a patient developing type 2 diabetes]
A J Scheen, N Paquot, B Jandrain
Diabetes & Metabolism
|
March 22, 2015
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
A J Scheen, N Esser, N Paquot
Revue Medicale De Liege
|
May 27, 2010
[Fitness versus fatness: respective cardiometabolic impacts at different age ranges]
N Esser, N Paquot, A J Scheen
Revue Medicale Suisse
|
September 16, 2006
[Drug therapy in the elderly. What should we know?]
P Wotquenne, J Petermans, A J Scheen
Diabetes & Metabolism
|
April 7, 2007
Abnormal glucose metabolism in patients treated with antipsychotics
A J Scheen, M A De Hert
Page
of 60